Julius Wolff Institut and Center for Musculoskeletal Surgery, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Berlin-Brandenburg Center for Regenerative Therapies, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Front Immunol. 2019 Aug 16;10:1954. doi: 10.3389/fimmu.2019.01954. eCollection 2019.
There is increasing evidence that T lymphocytes play a key role in controlling endogenous regeneration. Regeneration appears to be impaired in case of local accumulation of CD8+ effector T cells (T), impairing endogenous regeneration by increasing a primary "useful" inflammation toward a damaging level. Thus, rescuing regeneration by regulating the heightened pro-inflammatory reaction employing regulatory CD4+ T (T) cells could represent an immunomodulatory option to enhance healing. Hypothesis was that CD4+ T might counteract undesired effects of CD8+ T. Using adoptive T transfer, bone healing was consistently improved in mice possessing an inexperienced immune system with low amounts of CD8+ T. In contrast, mice with an experienced immune system (high amounts of CD8+ T) showed heterogeneous bone repair with regeneration being dependent upon the individual T/T ratio. Thus, the healing outcome can only be improved by an adoptive T therapy, if an unfavorable T/T ratio can be reshaped; if the individual CD8+ T percentage, which is dependent on the individual immune experience can be changed toward a favorable ratio by the T transfer. Remarkably, also in patients with impaired fracture healing the T/T ratio was higher compared to uneventful healers, validating our finding in the mouse osteotomy model. Our data demonstrate for the first time the key-role of a balanced T/T response following injury needed to reach successful regeneration using bone as a model system. Considering this strategy, novel opportunities for immunotherapy in patients, which are at risk for impaired healing by targeting T cells and supporting T cells to enhance healing are possible.
越来越多的证据表明,T 淋巴细胞在控制内源性再生中起着关键作用。在局部积聚 CD8+效应 T 细胞(T)的情况下,再生似乎受损,通过将主要的“有用”炎症增加到损害水平来损害内源性再生。因此,通过调节升高的促炎反应利用调节性 CD4+T(T)细胞来挽救再生可能代表一种增强愈合的免疫调节选择。假设 CD4+T 可能会抵消 CD8+T 的不良影响。通过过继性 T 细胞转移,在免疫系统不成熟、CD8+T 数量较少的小鼠中,骨愈合得到了一致改善。相比之下,具有经验丰富的免疫系统(高数量的 CD8+T)的小鼠表现出异质性的骨修复,再生取决于个体 T/T 比值。因此,只有通过过继性 T 细胞治疗来重塑不利的 T/T 比值,才能改善愈合结果;如果 T 细胞转移可以将个体 CD8+T 百分比(取决于个体免疫经验)改变为有利的比值,那么愈合结果才能改善。值得注意的是,在骨折愈合受损的患者中,T/T 比值也高于无并发症的愈合者,验证了我们在小鼠截骨模型中的发现。我们的数据首次证明,在使用骨骼作为模型系统进行成功再生时,损伤后需要平衡的 T/T 反应来发挥关键作用。考虑到这种策略,通过靶向 T 细胞并支持 T 细胞来增强愈合,为存在愈合受损风险的患者提供免疫治疗的新机会是可能的。